Company Search:
Advanced Search
Sponsored Links
Dar Al Dawa Development & Investment Company Snapshot
Dar Al Dawa Development & Investment operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Dar Al Dawa Development & Investment with three other pharmaceutical manufacturers in Middle East: Enzymotec Ltd of Israel (2015 sales of 195.82 million Israel Shekels [US$51.28 million] of which 107% was Nutrition), Egypt International Pharmaceuticals of Egypt (1.70 billion Egyptian Pounds [US$89.69 million] of which 100% was Pharmaceutical), and Glaxo Smith Kline which is also based in Egypt (1.02 billion Egyptian Pounds [US$53.96 million] of which 100% was Pharmaceutical Products).

Sales Analysis. Dar Al Dawa Development & Investment reported sales of 62.14 million Jordanian Dinars (US$87.77 million) for the year ending December of 2015. This represents a decrease of 9.9% versus 2014, when the company's sales were 68.97 million Jordanian Dinars. Contributing to the drop in overall sales was the 12.0% decline in Pharmaceuticals, from 55.17 million Jordanian Dinars to 48.57 million Jordanian Dinars. There were also decreases in sales in Infant Food and Milk (down 1.7% to 13.56 million Jordanian Dinars) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Dar Al Dawa Development & Investment
  Stock Performance Chart for Dar Al Dawa Development & Investment
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2017): 2.12
(Figures in Jordanian Dinars)
1 Week 0.0%   13 Weeks 0.0%  
4 Weeks -3.2%   52 Weeks -13.8%  
Dar Al Dawa Development & Investment Key Data:
  Ticker: DADI Country: Jordan
  Exchanges: AMN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 62,139,204
(Year Ending Jan 2016).
Employees: 1,050
  Currency: Jordanian Dinars Market Cap: 53,000,000
  Fiscal Yr Ends: December Shares Outstanding: 25,000,000
  Share Type: Ordinary Closely Held Shares: 12,874,500
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.